[![LegislationCrest](/images/crests/ukpga.gif)](/ukpga/2017/23/introduction/enacted?view=plain), # Health Service Medical Supplies (Costs) Act 2017, # 2017 CHAPTER 23, An Act to make provision in connection with controlling the cost of healthservice medicines and other medical supplies; to make provision in connectionwith the provision of pricing and other information by those manufacturing,distributing or supplying those medicines and supplies, and other relatedproducts, and the disclosure of that information; and for connected purposes., [27th April 2017], Be it enacted by the Queen’s most Excellent Majesty, by and with the adviceand consent of the Lords Spiritual and Temporal, and Commons, in this presentParliament assembled, and by the authority of the same, as follows:—, ## Controlling cost of health service medicines, ### 1Remuneration for persons providing special medicinal products: England, In section 164 of the National Health Service Act 2006 (remuneration forpersons providing pharmaceutical services), after subsection (8) insert—, “(8A)Regulations may impose requirements in relation to remuneration inrespect of special medicinal products., (8B)Such regulations may, for example, require determining authorities toensure—, (a)that remuneration is to be calculated by reference to the outcome ofprescribed procedures, or, (b)that determinations do not provide for or permit remuneration to be paid inprescribed circumstances., (8C)Procedures prescribed by virtue of subsection (8B)(a) may include theperson to whom remuneration is payable, a health service body or a determiningauthority—, (a)carrying out inquiries to ensure that remuneration is reasonable, or, (b)estimating an amount of remuneration that is reasonable (whether or not theestimated amount corresponds exactly to expenses in respect of whichremuneration is to be paid)., (8D)Circumstances prescribed by virtue of subsection (8B)(b) may includecircumstances in which special medicinal products are made available topersons who provide pharmaceutical services under this Part—, (a)by a health service body, or, (b)under an arrangement for the supply of special medicinal products to whicha health service body is a party., (8E)In subsections (8A) to (8D)—,   * “health service body” has the meaning given by section 9(4);,   * “special medicinal product” means a product which is a special medicinal product for the purposes of regulation 167 of the Human Medicines Regulations 2012 ([S.I. 2012/1916](/id/uksi/2012/1916?view=plain "Go to item of legislation")).”, ### 2Remuneration for persons providing special medicinal products: Wales, In section 88 of the National Health Service (Wales) Act 2006 (remunerationfor persons providing pharmaceutical services), after subsection (8) insert—, “(8A)Regulations may impose requirements in relation to remuneration inrespect of special medicinal products., (8B)Such regulations may, for example, require determining authorities toensure—, (a)that remuneration is to be calculated by reference to the outcome ofprescribed procedures, or, (b)that determinations do not provide for or permit remuneration to be paid inprescribed circumstances., (8C)Procedures prescribed by virtue of subsection (8B)(a) may include theperson to whom remuneration is payable, a health service body or a determiningauthority—, (a)carrying out inquiries to ensure that remuneration is reasonable, or, (b)estimating an amount of remuneration that is reasonable (whether or not theestimated amount corresponds exactly to expenses in respect of whichremuneration is to be paid)., (8D)Circumstances prescribed by virtue of subsection (8B)(b) may includecircumstances in which special medicinal products are made available topersons who provide pharmaceutical services under this Part—, (a)by a health service body, or, (b)under an arrangement for the supply of special medicinal products to whicha health service body is a party., (8E)In subsections (8A) to (8D)—,   * “health service body” has the meaning given by section 7(4);,   * “special medicinal product” means a product which is a special medicinal product for the purposes of regulation 167 of the Human Medicines Regulations 2012 ([S.I. 2012/1916](/id/uksi/2012/1916?view=plain "Go to item of legislation")).”, ### 3Voluntary schemes, (1)Section 261 of the National Health Service Act 2006 (voluntary schemes forcontrolling the cost of health service medicines) is amended as follows., (2)In subsection (1)—, (a)for “and 263” substitute “, 263 and 264A”,, (b)for “the purpose of” substitute “one or more of the following purposes”,, (c)omit the “or” before paragraph (b), and, (d)after paragraph (b) insert—, “(c)providing for any manufacturer or supplier to whom the scheme relates topay to the Secretary of State an amount calculated by reference to sales orestimated sales of any health service medicines (whether on the basis of netprices, average selling prices or otherwise).”, (3)In subsection (4) for “either” substitute “any”., (4)After subsection (8) insert—, “(9)The Secretary of State may provide for any amount payable in accordancewith a voluntary scheme by any manufacturer or supplier to whom the schemeapplies to be paid to the Secretary of State within a specified period., (10)Neither of the following affects any liability of a manufacturer orsupplier to pay amounts to the Secretary of State arising during a period whena health service medicine was covered by a voluntary scheme treated asapplying to the person or the taking of any action in relation to any suchliability—, (a)the withdrawal of consent by the person to the scheme being treated asapplying to the person;, (b)the giving of notice to the person under subsection (4).”, ### 4Power to control prices, For section 262(2) of the National Health Service Act 2006 (circumstances inwhich powers not exercisable) substitute—, “(2)If at any time a health service medicine is covered by a voluntary schemeapplying to its manufacturer or supplier, the powers conferred by this sectionmay not be exercised at that time in relation to that manufacturer or supplieras regards that medicine.”, ### 5Statutory schemes, (1)Section 263 of the National Health Service Act 2006 (statutory schemes forcontrolling the cost of health service medicines) is amended as follows., (2)In subsection (1)—, (a)after “body” insert “and any other person the Secretary of State thinksappropriate”,, (b)for “the purpose of” substitute “one or more of the following purposes”,, (c)omit the “or” before paragraph (b), and, (d)after paragraph (b) insert—, “(c)providing for any manufacturer or supplier of any health service medicinesto pay to the Secretary of State an amount calculated by reference to sales orestimated sales of those medicines (whether on the basis of net prices,average selling prices or otherwise).”, (3)After subsection (1) insert—, “(1A)Consultation about the proposed exercise of a power under subsection (1)must include consultation about the following—, (a)the economic consequences for the life sciences industry in the UnitedKingdom;, (b)the consequences for the economy of the United Kingdom;, (c)the consequences for patients to whom any health service medicines are tobe supplied and for other health service patients.”, (4)After subsection (5) insert—, “(5A)The scheme may provide for any amount payable in accordance with thescheme by any manufacturer or supplier to whom the scheme applies to be paidto the Secretary of State within a specified period.”, (5)For subsection (7) substitute—, “(7)If at any time a health service medicine is covered by a voluntary schemeapplying to its manufacturer or supplier, the powers conferred by this sectionmay not be exercised at that time in relation to that manufacturer or supplieras regards that medicine.”, (6)After subsection (7) insert—, “(8)Subsection (7) does not affect any liability of a person to pay amounts tothe Secretary of State arising during a period when a health service medicinewas covered by a statutory scheme applying to the person or the taking of anyaction in relation to any such liability.”, ### 6Enforcement, (1)The National Health Service Act 2006 is amended as follows., (2)Section 265 (enforcement) is amended as follows., (3)In subsection (4)—, (a)after “261(8)(b)” insert “or (9)”, and, (b)after “section 263(4), (5)” insert “, (5A)”., (4)After subsection (8) insert—, “(8A)Subsection (8) does not apply to any action by the Secretary of State torecover as a debt any amount required to be paid to the Secretary of State byvirtue of any of sections 261 to 263 or this section.”, (5)Section 266 (controls: supplementary) is amended as follows., (6)In subsection (1) (Secretary of State’s powers exercisable by makingregulations or giving directions) for “(8)” substitute “(9)”., (7)In subsection (3) after “section 263(1)” insert “(a) or (b)”., (8)In subsection (4) after “section 263(1)” insert “(a) and (b)”., (9)After subsection (4) insert—, “(4A)The power under section 263(1)(c) is exercisable only with a view torequiring payments to be made which would be reasonable in all thecircumstances, bearing in mind in particular—, (a)the need for medicinal products to be available for the health service onreasonable terms, and, (b)the costs of research and development.”, ## Controlling cost of other medical supplies, ### 7Control of maximum price of other medical supplies, (1)The National Health Service Act 2006 is amended as follows., (2)Section 260 (control of maximum price of medical supplies, other thanhealth service medicines) is amended in accordance with subsections (3) and(4)., (3)In subsection (1) for “this Act” substitute “the health service”., (4)After subsection (1) insert—, “(1A)Before making an order under subsection (1) the Secretary of State mustconsult any body which appears to the Secretary of State appropriate torepresent persons who manufacture, distribute or supply medical suppliesfalling within subsection (1).”, (5)In section 265 (enforcement)—, (a)in subsection (1) for “regulations or directions under sections 261”substitute “orders, regulations or directions under sections 260”,, (b)in subsection (5) for “261” substitute “260”, and, (c)in subsection (8) for “261” substitute “260”., (6)In section 266(6) (interpretation) for “261” substitute “260”., (7)In section 272(6) (orders, regulations, rules and directions subject toaffirmative procedure), after paragraph (a) insert—, “(aa)the first order under section 260,”., (8)In section 278(3) (provisions which extend to Scotland and NorthernIreland) for “261” substitute “260”., (9)In Schedule 22 (which makes further provision in relation to section 260)omit paragraph 1 (which specifies provision which may be made by an orderunder section 260)., ## Information about medical supplies etc, ### 8Provision of information to Secretary of State and disclosure, After section 264 of the National Health Service Act 2006 insert—, #### “264AProvision of information about health service products, (1)References in this section to a UK producer are to a person whomanufactures, distributes or supplies any UK health service products., (2)Regulations may require any UK producer to—, (a)record and keep information which the Secretary of State may require forthe purpose specified in subsection (3), and, (b)provide that information to the Secretary of State,, (subject to subsection (9))., (3)The purpose is that of enabling or facilitating any of the following—, (a)the determination of the payments to be made to any persons who provideprimary medical services under Part 4;, (b)the determination of the remuneration to be paid to any persons who providepharmaceutical services under Part 7;, (c)the consideration by the Secretary of State of whether—, (i)adequate supplies of English health service products are available, and, (ii)the terms on which those products are available represent value for money;, (d)the determination of the payments to be made to any persons who provideprimary medical services under Part 4 of the National Health Service (Wales)Act 2006;, (e)the determination of the remuneration to be paid to any persons who providepharmaceutical services under Part 7 of that Act;, (f)the consideration by the Welsh Ministers of whether—, (i)adequate supplies of Welsh health service products are available, and, (ii)the terms on which those products are available represent value for money;, (g)the determination of the payments to be made to any persons who provideprimary medical services under section 2C(1) of the National Health Service(Scotland) Act 1978 (“the 1978 Act”);, (h)the determination of the remuneration to be paid to any persons who providepharmaceutical care services under section 2CA(1) of the 1978 Act;, (i)the consideration by the Scottish Ministers of whether—, (i)adequate supplies of Scottish health service products are available, and, (ii)the terms on which those products are available represent value for money;, (j)the determination of the remuneration to be paid to any persons who provideprimary medical services or pharmaceutical services under Part 2 or 6 of theHealth and Personal Social Services (Northern Ireland) Order 1972 ([S.I.1972/1265 (N.I. 14)](/id/nisi/1972/1265?view=plain "Go to item oflegislation"));, (k)the consideration by a Northern Ireland department of whether—, (i)adequate supplies of Northern Ireland health service products areavailable, and, (ii)the terms on which those products are available represent value for money;, (l)the exercise by the Secretary of State of any powers under sections 260 to264 and 265;, (m)the operation of a voluntary scheme., (4)The information which the Secretary of State may require from a UK producerby virtue of this section includes the following—, (a)the price charged or paid by the producer for UK health service products;, (b)the price charged or paid by the producer for delivery or other services inconnection with the manufacturing, distribution or supply of UK health serviceproducts;, (c)the discounts or rebates or other payments given or received by theproducer in connection with the manufacturing, distribution or supply of UKhealth service products;, (d)the revenue or profits accrued to the producer in connection with themanufacturing, distribution or supply of UK health service products(including, in relation to profits, the costs incurred by the producer inconnection with the manufacturing, distribution or supply of the products);, (e)such information about medicinal products, other medical supplies or otherrelated products as is necessary to verify whether they are UK health serviceproducts and, if so, which of the following they are—, (i)English health service products;, (ii)Welsh health service products;, (iii)Scottish health service products;, (iv)Northern Ireland health service products., (5)Regulations under this section must require the Secretary of State to givea UK producer an information notice if information is required in respect ofthe costs incurred by the producer in connection with the manufacturing,distribution or supply of a particular UK health service product (other thancosts which relate to any transaction between the producer and a UK producerfor that product)., (6)An information notice is a notice stating—, (a)the period in relation to or for which, or intervals at which, informationis required to be provided,, (b)the form and manner in which information is required to be provided,, (c)the time at which or period within which information is required to beprovided, and, (d)that a right of appeal is conferred by virtue of section 265(5A)., (7)Regulations under this section may require information which does not fallwithin subsection (5) to be provided—, (a)in relation to or for a prescribed period or at prescribed intervals,, (b)in a prescribed form and manner, and, (c)at a prescribed time or within a prescribed period., (8)The provision of information by virtue of this section does not breach—, (a)any obligation of confidence owed by the person providing it, or, (b)any other restriction on the provision of information (however imposed)., (9)Regulations under this section may not do any of the following—, (a)require any person who provides primary medical services under Part 4 ofthe National Health Service (Wales) Act 2006, or any person who providespharmaceutical services under Part 7 of that Act, to record, keep or provideinformation relating to any Welsh health service products which are suppliedby the person in providing the services in question;, (b)require any person who provides primary medical services under section2C(1) of the 1978 Act, or any person who provides pharmaceutical care servicesunder section 2CA(1) of that Act, to record, keep or provide informationrelating to any Scottish health service products which are supplied by theperson in providing the services in question;, (c)require any person who provides primary medical services or pharmaceuticalservices under Part 2 or 6 of the Health and Personal Social Services(Northern Ireland) Order 1972 ([S.I. 1972/1265 (N.I.14)](/id/nisi/1972/1265?view=plain "Go to item of legislation")) to record,keep or provide information relating to Northern Ireland health serviceproducts which are supplied by the person in providing the services inquestion., (10)“English health service products” means any medicinal products used to anyextent for the purposes of the health service continued under section 1(1) andany other medical supplies, or other related products, required for thepurposes of that health service., (11)“Medical supplies” is to be read in accordance with section 260(5)., (12)“Northern Ireland health service products” means any medicinal productsused to any extent for the purposes of health care provided by virtue of theHealth and Social Care (Reform) Act (Northern Ireland) 2009 and any othermedical supplies, or other related products, required for the purposes ofhealth care provided by virtue of that Act., (13)“Scottish health service products” means any medicinal products used toany extent for the purposes of the health service within the meaning of the1978 Act and any other medical supplies, or other related products, requiredfor the purposes of that health service., (14)“UK health service products” means any English health service products,Welsh health service products, Scottish health service products or NorthernIreland health service products., (15)“Welsh health service products” means any medicinal products used to anyextent for the purposes of the health service continued under section 1(1) ofthe National Health Service (Wales) Act 2006 and any other medical supplies,or other related products, required for the purposes of that health service., (16)Until the coming into force of the repeal of section 27 of the 1978 Act byschedule 3 to the Smoking, Health and Social Care (Scotland) Act 2005 thereferences in subsections (3)(h) and (9)(b) to pharmaceutical care servicesunder section 2CA(1) of the 1978 Act are to be read as references topharmaceutical services under section 27(1) of that Act., #### 264BDisclosure of information, (1)Information provided by virtue of section 264A may be disclosed by theSecretary of State to any of the following persons—, (a)the Board;, (b)any Special Health Authority;, (c)the Health and Social Care Information Centre;, (d)any government department;, (e)the Welsh Ministers;, (f)the Scottish Ministers;, (g)the Common Services Agency for the Scottish Health Service constitutedunder section 10 of the 1978 Act;, (h)a Northern Ireland department;, (i)the Regional Business Services Organisation established under section 14 ofthe Health and Social Care (Reform) Act (Northern Ireland) 2009;, (j)any person who provides services to any person falling within any ofparagraphs (a) to (i);, (k)any prescribed body appearing to the Secretary of State to represent UKproducers;, (l)such of the following as may be prescribed—, (i)an NHS foundation trust;, (ii)any health service body within the meaning of section 9(4) (not fallingwithin any of paragraphs (a) to (k) above)., (2)A person to whom any confidential or commercially sensitive information isdisclosed under subsection (1) may not—, (a)use the information for any purpose other than the purpose specified inrelation to that person in subsection (3), or, (b)disclose the information to another person (subject to subsection (4))., (3)For the purposes of subsection (2)—, (a)in relation to a person falling within subsection (1)(a) to (c), thepurpose is that of exercising functions connected with any of the mattersspecified in section 264A(3)(a) to (c), (l) or (m);, (b)in relation to a person falling within subsection (1)(d), the purpose isthat of—, (i)exercising functions connected with any of the matters specified in section264A(3)(a) to (c), (l) or (m), or, (ii)preventing, detecting or investigating any unlawful activities;, (c)in relation to a person falling within subsection (1)(e), the purpose isthat of exercising functions connected with any of the matters specified insection 264A(3)(d) to (f), (l) or (m);, (d)in relation to a person falling within subsection (1)(f) or (g), thepurpose is that of exercising functions connected with any of the mattersspecified in section 264A(3)(g) to (i), (l) or (m);, (e)in relation to a person falling within subsection (1)(h) or (i), thepurpose is that of exercising functions connected with any of the mattersspecified in section 264A(3)(j) to (m);, (f)in relation to a person falling within subsection (1)(j), the purpose isthat of providing services in connection with any purpose specified inrelation to the person for whom the services are provided in any of paragraphs(a) to (e) above;, (g)in relation to a person falling within subsection (1)(k) or (l), thepurpose is any prescribed purpose connected with any of the matters specifiedin section 264A(3)., (4)The Welsh Ministers may disclose any confidential or commercially sensitiveinformation disclosed to them under subsection (1) to any of the followingpersons—, (a)a Local Health Board or other person appointed under section 88(3)(b) ofthe National Health Service (Wales) Act 2006 to exercise the functions of adetermining authority under Part 7 of that Act;, (b)a National Health Service trust established under section 18 of theNational Health Service (Wales) Act 2006;, (c)any person who provides services to the Welsh Ministers or to any personfalling within paragraph (a) or (b)., (5)A person to whom any confidential or commercially sensitive information isdisclosed under subsection (4) may not—, (a)use the information for any purpose other than the purpose of exercisingfunctions connected with any of the matters specified in section 264A(3)(d) to(f), (l) or (m), or, (b)disclose the information to another person., #### 264CSections 264A and 264B: supplementary, (1)Before making regulations under section 264A or 264B the Secretary of Statemust consult any body which appears to the Secretary of State appropriate torepresent UK producers., (2)Nothing in section 264A or 264B requires information to be provided, orauthorises information to be disclosed or used, in contravention of the DataProtection Act 1998., (3)Nothing in section 264A or 264B affects any duties, obligations or powersto require or authorise information to be provided, disclosed or used whichexist apart from that section.”, ### 9Provision of information to Welsh Ministers and disclosure, “After section 201 of the National Health Service (Wales) Act 2006 insert—, #### Provision of information about medical supplies etc, ##### 201AProvision of information by persons providing primary medicalservices or pharmaceutical services, (1)Regulations may make provision requiring any Part 4 provider or Part 7provider to—, (a)record and keep information, or information of a description, specified inthe regulations, and, (b)provide that information to the Welsh Ministers., (2)Information, or a description of information, may not be specified in theregulations by virtue of subsection (1) unless the Welsh Ministers considerthat the information may be required for the purpose of enabling orfacilitating any of the following—, (a)the determination of the payments to be made to any Part 4 providers;, (b)the determination of the remuneration to be paid to any Part 7 providers;, (c)the consideration by the Welsh Ministers of whether—, (i)adequate supplies of health service products are available, and, (ii)the terms on which those products are available represent value for money., (3)The information which the Welsh Ministers may require from a Part 4provider or Part 7 provider by virtue of this section includes the following—, (a)the price charged or paid by the provider for health service products;, (b)the price paid by the provider for delivery or other services in connectionwith health service products;, (c)the discounts or rebates or other payments given or received by theprovider in connection with the supply of health service products;, (d)the revenue or profits accrued to the provider in connection with thesupply of health service products;, (e)such information about medicinal products, other medical supplies or otherrelated products as is necessary to verify whether or not they are healthservice products., (4)Regulations under this section may require information to be provided insuch form and manner, and at such time or within such period, as may beprescribed., (5)Regulations under this section may provide for a person who contravenes anyprovision of the regulations to be liable to pay a penalty to the WelshMinisters., (6)The penalty may be—, (a)a single penalty not exceeding £10,000, or, (b)a daily penalty not exceeding £100 for every day on which the contraventionoccurs or continues., (7)If regulations under this section make provision by virtue of subsection(5) they must include provision conferring on Part 4 providers and Part 7providers a right of appeal against a decision of the Welsh Ministers toimpose a penalty., (8)The provision of information by virtue of this section does not breach—, (a)any obligation of confidence owed by the person providing it, or, (b)any other restriction on the provision of information (however imposed)., (9)The Welsh Ministers may by regulations increase (or further increase)either of the sums mentioned in subsection (6)., (10)In this section—,   * “health service products” means any medicinal products used to any extent for the purposes of the health service continued under section 1(1) and any other medical supplies, or other related products, required for the purposes of that health service;,   * “medical supplies” includes surgical, dental and optical materials and equipment (and for this purpose “equipment” includes any machinery, apparatus or appliance, whether fixed or not, and any vehicle);,   * “medicinal product” has the meaning given by section 130 of the Medicines Act 1968;,   * “Part 4 provider” means a person who provides primary medical services under Part 4;,   * “Part 7 provider” means a person who provides pharmaceutical services under Part 7., ##### 201BDisclosure of information, (1)Information provided by virtue of section 201A may be disclosed by theWelsh Ministers to any of the following persons—, (a)a Local Health Board or other person appointed under section 88(3)(b) toexercise the functions of a determining authority under Part 7;, (b)an NHS trust established under section 18;, (c)any person who provides services to the Welsh Ministers or to any personfalling within paragraph (a) or (b);, (d)any body which appears to the Welsh Ministers appropriate to represent Part4 providers or Part 7 providers (as defined by section 201A(10))., (2)A person to whom any confidential or commercially sensitive information isdisclosed under subsection (1) may not—, (a)use the information for a purpose other than a purpose specified in section201A(2), or, (b)disclose the information to another person., ##### 201CSections 201A and 201B: supplementary, (1)Before making regulations under section 201A the Welsh Ministers mustconsult any body which appears to the Welsh Ministers appropriate to representPart 4 providers or Part 7 providers., (2)Nothing in section 201A or 201B requires information to be provided, orauthorises information to be disclosed or used, in contravention of the DataProtection Act 1998., (3)Nothing in section 201A or 201B affects any duties, obligations or powersto require or authorise information to be provided, disclosed or used whichexist apart from that section.”, ## Supplementary and final provisions, ### 10Consequential amendments, (1)Omit the following provisions of the National Health Service (Scotland) Act1978—, (a)section 49 (control of maximum prices for medical supplies other thanhealth service medicines), and, (b)Schedule 10 (additional provisions as to control of maximum prices formedical supplies other than health service medicines)., (2)The National Health Service Act 2006 is amended as follows., (3)In section 260 (control of maximum price of medical supplies other thanhealth service medicines)—, (a)omit subsections (2) to (4), and, (b)in subsection (5) omit—, (i)“and Schedule 22”, and, (ii)the definition of “undertaking” (and the “and” before it)., (4)In section 261 (powers relating to voluntary schemes) omit subsection (7)., (5)In section 263 (statutory schemes)—, (a)in subsection (2) for “(3)” substitute “(4)”, and, (b)omit subsection (3)., (6)In section 264 (statutory schemes: supplementary) omit subsection (2)., (7)Section 265 (enforcement) is amended in accordance with subsections (8) to(14)., (8)In subsection (1) for “264” substitute “264A”., (9)In subsection (5)—, (a)the words from “conferring” to the end become paragraph (a), and, (b)after paragraph (a) insert “, and, (b)conferring on UK producers a right of appeal against enforcement decisionstaken in respect of them in pursuance of section 264A and this section (otherthan enforcement decisions falling within subsection (5A)).”, (10)After subsection (5) insert—, “(5A)Provision must be made by regulations for conferring on UK producers aright of appeal against enforcement decisions taken in respect of them inpursuance of section 264A and this section if the enforcement decisions relateto information notices given by virtue of section 264A(5).”, (11)In subsection (7)(a) and (d) after “supplier” insert “, or other personwho is a UK producer,”., (12)In subsection (8) for “264” substitute “264A”., (13)For subsection (9) substitute—, “(9)Before making any regulations under this section the Secretary of Statemust consult the industry body and any other body which appears to theSecretary of State appropriate to represent UK producers.”, (14)After subsection (10) insert—, “(11)In this section “UK producer” is to be read in accordance with section264A.”, (15)In section 271 (territorial limit of exercise of functions), in subsection(3)(i) omit “and Schedule 22”., (16)In section 272 (orders, regulations, rules and directions) omit subsection(9)., (17)In section 278 (extent), in subsection (3), after “supplies)” insert “,and this Part to the extent that it applies to those sections,”., (18)In Schedule 22 (provisions in relation to section 260) omit paragraphs 2to 11., (19)In section 203(6) of the National Health Service (Wales) Act 2006(statutory instruments which are subject to affirmative procedure) after“section 25B(3)(c) or” insert “201A(9) or”., ### 11Extent, (1)Subject as follows, this Act extends to England and Wales, Scotland andNorthern Ireland., (2)Sections 1, 2, 9 and 10(19) extend to England and Wales only., (3)Section 10(1) extends to Scotland only., ### 12Commencement, (1)Section 11, this section and section 13 come into force on the day on whichthis Act is passed., (2)Sections 2, 9 and 10(19) come into force on such day as the Welsh Ministersmay by order appoint., (3)The remaining provisions of this Act come into force on such day as theSecretary of State may by regulations appoint., (4)An order or regulations under this section may—, (a)appoint different days, or make different provision, for different purposesor areas, and, (b)make transitional, transitory or saving provision., (5)An order or regulations under this section is or are to be made bystatutory instrument., ### 13Short title, This Act may be cited as the Health Service Medical Supplies (Costs) Act 2017., 